The key component of treating B-cell acute lymphoblastic leukemia (B-ALL) is pegylated (PEG)-asparaginase with glucocorticoids and other chemotherapeutic agents [1]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.